Upcoming Events
  1. Consumer training workshops

    July 17 @ 12:30 pm - 2:00 pm
  2. Conducting systematic reviews: A short course for thoracic oncology nurses

    August 5 @ 6:30 pm
  3. 6th ALTG Lung Cancer Preceptorship

    October 23 @ 10:00 am - October 24 @ 3:30 pm
  4. ALTG open MAC and SAC meetings

    November 20

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

Lung Foundation Australia News – New Lung Cancer Resources Launched

Two new, complementary national resources for lung cancer have been launched as part of the National Lung Cancer Program – the first national directory of dedicated lung cancer MDTs and the Lung Cancer Patient Pathway.

The Lung Cancer Multi-Disciplinary Teams (MDT) Directory 

The Lung Cancer MDT Directory is the first national directory of its kind and has been developed as a service for clinicians, patients and consumers. It is intended to facilitate referrals of patients to hospitals delivering MDT-based lung cancer management. The MDT Directory allows users to search by location or browse by state; lists the available MDTs; and provides details about each MDT’s diagnostic and treatment modalities, team composition and referral pathway. Contact Claire Mulvihill, Lung Cancer Support Nurse for more information.

Lung Cancer Patient Pathway (LCPP) 

The LCPP is a tool for use with patients, ideally to be introduced at the time of diagnosis, to assist in navigating them through understanding their diagnosis along with their proposed treatment plan.

There are two main components to the pathway:

  • A visual representation, in the form of “stepping stones”, of the steps that are generally involved in a lung lung-cancer-pathwaycancer journey, beginning with referral to a specialist;
  • “Your lung cancer profile” is a section for clinical staff (or the patient) to record information about their individual situation.

The LCCP is available in hard copy (as a tear-off pad) and can be obtained by contacting Lung Foundation Australia via FREE CALL 1800 654 301 or enquiries@lungfoundation.com.au .

A complementary electronic version of the LCPP is also available on the Lung Foundation website and provides detailed information for each of the “stepping stones” in the LCPP with links to the Lung Foundation’s “Better Living with Lung Cancer” resource.